LT3083648T - Farmacinis būdas ir tarpiniai junginiai - Google Patents

Farmacinis būdas ir tarpiniai junginiai

Info

Publication number
LT3083648T
LT3083648T LTEP14828102.5T LT14828102T LT3083648T LT 3083648 T LT3083648 T LT 3083648T LT 14828102 T LT14828102 T LT 14828102T LT 3083648 T LT3083648 T LT 3083648T
Authority
LT
Lithuania
Prior art keywords
intermediates
pharmaceutical process
pharmaceutical
Prior art date
Application number
LTEP14828102.5T
Other languages
English (en)
Inventor
Benedict MCKEEVER
Louis Diorazio
Martin Jones
Leigh FERRIS
Sophie JANBON
Pawel Siedlecki
Gwydion Churchill
Peter CRAFTS
Original Assignee
Rigel Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals, Inc. filed Critical Rigel Pharmaceuticals, Inc.
Publication of LT3083648T publication Critical patent/LT3083648T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP14828102.5T 2013-12-20 2014-12-19 Farmacinis būdas ir tarpiniai junginiai LT3083648T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361919671P 2013-12-20 2013-12-20
PCT/US2014/071613 WO2015095765A1 (en) 2013-12-20 2014-12-19 Pharmaceutical process and intermediates

Publications (1)

Publication Number Publication Date
LT3083648T true LT3083648T (lt) 2019-01-25

Family

ID=52358996

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14828102.5T LT3083648T (lt) 2013-12-20 2014-12-19 Farmacinis būdas ir tarpiniai junginiai

Country Status (17)

Country Link
US (2) US9388203B2 (lt)
EP (1) EP3083648B1 (lt)
JP (1) JP6522005B2 (lt)
CN (1) CN105849115B (lt)
CA (2) CA3186267C (lt)
CY (1) CY1121313T1 (lt)
DK (1) DK3083648T3 (lt)
ES (1) ES2701088T3 (lt)
HR (1) HRP20181933T1 (lt)
HU (1) HUE042204T2 (lt)
LT (1) LT3083648T (lt)
PL (1) PL3083648T3 (lt)
PT (1) PT3083648T (lt)
RS (1) RS58084B1 (lt)
SI (1) SI3083648T1 (lt)
SM (1) SMT201800644T1 (lt)
WO (1) WO2015095765A1 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109912622A (zh) * 2019-03-20 2019-06-21 中国药科大学 一种福他替尼关键中间体的制备方法及其中间体和利用中间体制备福他替尼的方法
CN118702735B (zh) * 2024-07-15 2025-12-30 河北常山生化药业股份有限公司 福坦替尼杂质及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4886511B2 (ja) 2003-07-30 2012-02-29 ライジェル ファーマシューティカルズ, インコーポレイテッド 2,4−ピリミジンジアミン化合物による自己免疫疾患の治療または予防方法
CN101115761B (zh) 2005-01-19 2012-07-18 里格尔药品股份有限公司 2,4-嘧啶二胺化合物的前药及其应用
EP2420505A1 (en) * 2006-11-21 2012-02-22 Rigel Pharmaceuticals, Inc. Prodrug salts of 2, 4- pyrimidinediamine compounds and their uses
UA108077C2 (xx) * 2009-07-02 2015-03-25 Синтез динатрієвої солі n4-(2,2-диметил-4-$(дигідрофосфонокси)метил]-3-оксо-5-піридо$1,4]оксазин-6-іл)-5-фтор-n2-(3,4,5-триметоксифеніл)-2,4-піримідиндіаміну
WO2011063241A1 (en) * 2009-11-20 2011-05-26 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses

Also Published As

Publication number Publication date
US9388203B2 (en) 2016-07-12
CA2934535C (en) 2023-03-28
DK3083648T3 (en) 2019-01-07
US20150175639A1 (en) 2015-06-25
PL3083648T3 (pl) 2019-05-31
SMT201800644T1 (it) 2019-01-11
EP3083648B1 (en) 2018-09-12
CA3186267A1 (en) 2015-06-25
US20160355531A1 (en) 2016-12-08
SI3083648T1 (sl) 2019-02-28
ES2701088T3 (es) 2019-02-20
CN105849115A (zh) 2016-08-10
HUE042204T2 (hu) 2019-06-28
US9695204B2 (en) 2017-07-04
WO2015095765A1 (en) 2015-06-25
CA3186267C (en) 2025-09-09
CN105849115B (zh) 2019-06-11
CA2934535A1 (en) 2015-06-25
CY1121313T1 (el) 2020-05-29
JP6522005B2 (ja) 2019-05-29
EP3083648A1 (en) 2016-10-26
HRP20181933T1 (hr) 2019-01-11
JP2017503018A (ja) 2017-01-26
RS58084B1 (sr) 2019-02-28
PT3083648T (pt) 2018-12-14

Similar Documents

Publication Publication Date Title
ZA201905426B (en) Drug combinations
GB201520943D0 (en) Novel linker and preparation method thereof
GB201309173D0 (en) Novel process and product
SG11201508447TA (en) Expression process
LT2943561T (lt) Foto bioreaktorius
GB201301639D0 (en) Product and process
IL242943A0 (en) A process for the preparation of abiraterone and its intermediates
GB201323132D0 (en) New products and processes
GB201322992D0 (en) New Process
HUP1300033A2 (en) Improved process for producing pharmaceutical agent and intermediate
GB201302441D0 (en) Process
GB201300073D0 (en) Process
HRP20181933T1 (hr) Farmaceutski postupak i intermedijari
SG11201602693QA (en) Methods and intermediates for preparing macrolactams
GB201317756D0 (en) New process
GB201313211D0 (en) New process
GB201311837D0 (en) Expression Process
HUP1300722A2 (en) Norsteroid intermediates and process for their preparation
GB201321103D0 (en) Novel process and products
GB201318453D0 (en) Novel method and products
GB201304585D0 (en) Methods and product
GB201310496D0 (en) Pharmaceutical combinations
GB201317888D0 (en) Method and product
GB201301723D0 (en) Pharmaceutical combinations
GB201300358D0 (en) Method and product